COLUMBIA LABORATORIES (CBRX) 1.15 $0.00 (0.00%) 10:06AM (15 mins delay)

CBRX

$1.15 $0.00 (0.00%)

You need to upgrade your Flash Player

Today

10y

Last:	$1.15	High:	-
Prev Close:	$1.15	Low:	-
Open:	-	Mkt Cap:	$75M
Change:	$0.00 ( 0.00% )	52Wk High:	$1.70
Vol:	0	52Wk Low:	$0.65
Avg Volume:	745,449	Shares:	65.60B
EPS:	-0.39	PE Ratio:	-

Start trading CBRX with real money!

Company Description

The Company is engaged in the research, development and commercialization of women's healthcare and endocrinology products, including treat infertility, endometriosis, dysmenorrhea and preterm birth.

	Paul & Shark	Mar 04 3:30 PM
	SELL NOW www.mkapital.com - CBRX Comment

	Emily jo Smith	Jan 20 1:41 PM
	Everybody type in Columbia and go to Columbia Laboratories it is doing awesome!!!!!!!!!! - CBRX Comment

	Emily jo Smith	Jan 20 1:41 PM
	Everybody type in Columbia and go to Columbia Laboratories it is doing awesome!!!!!!!!!! - CBRX Comment

COLUMBIA LABORATORIES (CBRX) Stock News & Analysis

A preliminary proxy statement relating to a merger or acquisition - Form PREM14A	Yesterday	SEC Filings
An amendment to a SC 13D filing - Form SC 13D/A	03/18/2010	SEC Filings
Additional proxy soliciting materials - definitive - Form DEFA14A	03/15/2010	SEC Filings
Report of unscheduled material events or corporate changes - Form 8-K	03/12/2010	SEC Filings
Filing by person(s) reporting owned shares of common stock in a public company >5% - Form SC 13D	03/12/2010	SEC Filings
Annual report which provides a comprehensive overview of the company for the past year - Form 10-K	03/12/2010	SEC Filings
Report of unscheduled material events or corporate changes - Form 8-K	03/12/2010	SEC Filings
Additional proxy soliciting materials - definitive - Form DEFA14A	03/12/2010	SEC Filings
CORRECTING and REPLACING Columbia Laboratories Reports Fourth Quarter and Year End 2009 Financial Results	03/11/2010
Columbia Laboratories Reports Fourth Quarter and Year End 2009 Financial Results	03/11/2010
Report of unscheduled material events or corporate changes - Form 8-K	03/11/2010	SEC Filings
Additional proxy soliciting materials - definitive - Form DEFA14A	03/11/2010	SEC Filings
Columbia Laboratories Will Discuss Fourth Quarter and Year-End 2009 Financial Results on March 11, 2010 Conference Call	03/05/2010
Today's Big Losers: INOD, CBRX, CIEN	03/04/2010
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise	03/04/2010